Clinical Trial: Treatment of TNNT1-Myopathy With L-Tyrosine.
Study Status: Terminated
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.
Brief Summary: The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.
Detailed Summary:
Sponsor: Hadassah Medical Organization
Current Primary Outcome: 1. goal attainment score [ Time Frame: 3 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Hadassah Medical Organization
Dates:
Date Received: July 2, 2013
Date Started: January 2014
Date Completion:
Last Updated: January 13, 2014
Last Verified: January 2014